How to become a CHAMPION in LAA closure

Sponsored by Boston Scientific

Anchorperson: J. E. Nielsen-Kudsk

Spokesperson: M. Grygier

Summary

This session reviews the latest CHAMPION AF trial data and its implications for left atrial appendage (LAA) closure in patients with atrial fibrillation.

It explores how emerging evidence may influence clinical practice and patient selection, and how LAA closure could evolve across different atrial fibrillation populations.

A recorded case illustrates contemporary workflows using the WATCHMAN portfolio as an integrated solution for LAA closure, highlighting practical aspects of device-based treatment.

Overall, the session discusses how new clinical data are shaping the future role of LAA closure within broader atrial fibrillation management strategies.

Learning Objectives

To learn about the recently-published CHAMPION AF data and discuss its implications on clinical practice
To observe a recorded case using the WATCHMAN portfolio as an integrated, all-in-one LAA closure solution
To discuss how emerging evidence may influence the evolving role of LAA closure across different atrial fibrillation patient populations